Last reviewed · How we verify

NCT07083518

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Active, enrolled NA Last updated 24 July 2025
What this trial tests

NA trial testing Anodal transcranial direct current stimulation in Transcranial Direct Current Stimulation (tDCS) in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
29 May 2025
Primary endpoint
31 December 2026
31 December 2027

Quick facts

Lead sponsorAnhui Medical University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date29 May 2025
Primary completion31 December 2026
Estimated completion31 December 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Anhui Medical University

Who can join

Adults 18 to 65, female only, with Transcranial Direct Current Stimulation (tDCS) or Breast Cancer Survivor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the efficacy of transcranial direct current stimulation (tDCS) in improving cancer-related cognitive impairment (CRCI) in breast cancer survivors. Participants will be randomly assigned to receive active or sham stimulation over the prefrontal cortex. Cognitive outcomes will be assessed using standardized neuropsychological tests and self-reported measures. Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) will be used to explore neural correlates of intervention effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Anodal transcranial direct current stimulation

Trials testing the same drug.

Other Anhui Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07083518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing